Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Christian Teacher’s Rights Rejected

A federal judge in Indianapolis this week rejected an argument…
Read more

St. Jude children’s hospital to employees: Get vaccinated or get fired

World-renowned St. Jude Children's Research Hospital is now…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Mike Pence: ‘Biden-Harris Administration Is Already Rolling over to Communist China’

Former Vice President Mike Pence, while speaking at the Heritage…
Read more